Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
88805201000001115 | Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
88805301000001112 | Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Duaklir 340micrograms/dose /12micrograms/dose Genuair (Almirall Ltd) | Is a | True | Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler | Inferred relationship | Existential restriction modifier | |
Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler 60 dose | Has VMP | True | Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler | Inferred relationship | Existential restriction modifier | |
Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) | Is a | False | Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets